MODERATE-TO-SEVERE ASTHMA
Clinical trials for MODERATE-TO-SEVERE ASTHMA explained in plain language.
Never miss a new study
Get alerted when new MODERATE-TO-SEVERE ASTHMA trials appear
Sign up with your email to follow new studies for MODERATE-TO-SEVERE ASTHMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill could help asthma sufferers breathe easier
Disease control Not yet recruitingThis study tests a new drug, linvemastat, for adults with moderate-to-severe asthma that is not fully controlled by standard inhalers. About 135 participants will receive either one of two doses of linvemastat or a placebo, while continuing their usual medications. Over 16 weeks,…
Matched conditions: MODERATE-TO-SEVERE ASTHMA
Phase: PHASE2 • Sponsor: Foresee Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Could a spinal implant tame Hard-to-Control asthma?
Disease control Not yet recruitingThis study tests whether a device that stimulates the spinal cord — called pulmonary neuromodulation — can improve asthma control in adults with moderate to severe asthma that remains uncontrolled despite high-dose inhalers or biologic medications. Participants receive the implan…
Matched conditions: MODERATE-TO-SEVERE ASTHMA
Phase: NA • Sponsor: Spiro Medical, Inc. • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
New asthma shot aims to help patients breathe easier
Disease control Not yet recruitingThis Phase 2 trial tests an injectable drug called RC1416 in 195 adults with moderate to severe asthma that is not well controlled. Participants will receive either the drug or a placebo by injection. The study will measure changes in lung function and track asthma attacks over t…
Matched conditions: MODERATE-TO-SEVERE ASTHMA
Phase: PHASE2 • Sponsor: Nanjing RegeneCore Biotech Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC